New drug aims to shrink heart artery blockages

NCT ID NCT06700720

First seen Jan 08, 2026 · Last updated May 11, 2026 · Updated 22 times

Summary

This study tests a new medicine called YN001 in 24 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants receive YN001 by IV along with a standard cholesterol-lowering drug. The goal is to see if YN001 can reduce plaque volume and improve artery health. The study is in Phase 2a and is recruiting in Australia.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Albury Wodonga Private Hospital

    RECRUITING

    Albury, New South Wales, 1125, Australia

    Contact

  • Altona Clinical Research

    RECRUITING

    Melbourne, Victoria, 3025, Australia

    Contact

  • Canberra Hospital

    RECRUITING

    Canberra, Australian Capital Territory, Australia

    Contact

  • Core Research Group Pty Ltd

    WITHDRAWN

    Milton, Queesland, Australia

  • John Flynn Private Hospital

    NOT_YET_RECRUITING

    Tugun, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peninsula Heart Centre

    RECRUITING

    Melbourne, Victoria, 3199, Australia

    Contact

  • Sunshine Coast University Private Hospital

    RECRUITING

    Birtinya, Queensland, 4575, Australia

    Contact

Conditions

Explore the condition pages connected to this study.